AdaptHealth Corp. (AHCO)
NASDAQ: AHCO · Real-Time Price · USD
6.27
+0.23 (3.81%)
Sep 3, 2026, 1:03 PM EDT - Market open
AdaptHealth Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3,363 | 3,245 | 3,261 | 3,200 | 2,971 | 2,465 |
Revenue Growth | 13.47% | -0.49% | 1.90% | 7.73% | 20.51% | 130.24% |
Gross Profit Gross Profit Growth | 644.93 | 677.93 | 749.16 | 681.77 | 634.32 | 524.54 |
Operating Income Operating Income Growth | 158.5 | 204.57 | 288.25 | 278.53 | 216.11 | 225.61 |
Net Income Net Income Growth | -227.6 | -70.79 | 82.75 | -678.9 | 63.45 | 141.8 |
Earnings Per Share EPS Growth | -1.68 | -0.52 | 0.61 | -5.31 | 0.33 | 0.67 |
EPS Growth | - | - | - | - | -50.00% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Wellness At Home Wellness At Home Growth | 571.14 | 583.14 | 646.2 | 633.86 | 625.59 |
Sleep Health Sleep Health Growth | 1,472 | 1,378 | 1,349 | 1,292 | 1,104 |
Respiratory Health Respiratory Health Growth | 727.77 | 691.16 | 651.15 | 614.56 | 554.14 |
Diabetes Health Diabetes Health Growth | - | 592.41 | 614.41 | 660.04 | 687.09 |
Total Total Growth | 3,363 | 3,245 | 3,261 | 3,200 | 2,971 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 43.29 | 106.24 | 112.65 | 81.61 | 52.02 | 149.63 |
Total Debt Total Debt Growth | 2,065 | 1,903 | 2,130 | 2,295 | 2,329 | 2,378 |
Net Cash (Debt) Net Cash Growth | -2,022 | -1,797 | -2,018 | -2,213 | -2,277 | -2,229 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -14.90 | -13.29 | -14.89 | -16.46 | -16.38 | -16.75 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 583.27 | 601.77 | 541.84 | 480.67 | 373.87 | 275.68 |
Capital Expenditures CapEx Growth | -485.59 | -382.39 | -306.06 | -337.46 | -391.42 | -203.31 |
Free Cash Flow Free Cash Flow Growth | 97.68 | 219.38 | 235.78 | 143.2 | -17.56 | 72.37 |
Free Cash Flow Growth | -57.75% | -6.96% | 64.65% | - | - | -53.57% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 19.18% | 20.89% | 22.97% | 21.30% | 21.35% | 21.28% |
Operating Margin | 4.71% | 6.30% | 8.84% | 8.70% | 7.27% | 9.15% |
Pretax Margin | -6.98% | -0.47% | 4.17% | -22.62% | 3.30% | 7.75% |
Profit Margin | -6.77% | -2.18% | 2.54% | -21.21% | 2.14% | 5.75% |
FCF Margin | 2.90% | 6.76% | 7.23% | 4.47% | -0.59% | 2.94% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 15.14 | - | 40.81 | 22.81 |
Forward PE | - | 11.60 | 9.91 | 9.86 | 15.29 | 15.36 |
P/FCF Ratio | 8.25 | 6.02 | 5.31 | 6.87 | - | 44.69 |
PS Ratio | 0.24 | 0.41 | 0.38 | 0.31 | 0.87 | 1.31 |